NCT00428935 - Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2010

Conditions

Duchenne Muscular Dystrophy

Interventions

BIOLOGICAL

rAAV2.5-CMV-minidystrophin (d3990)

Recombinant adeno-associated virus (AAV) carrying a truncated human dystrophin gene (mini-dystrophin) expressed from a cytomegalovirus (CMV) promoter.

Trial Locations (1)

43205

Columbus Children's Hospital, Columbus